NIH-funded research R01 grant

Investigating the role of a specific microRNA in improving blood flow in diabetic patients with critical limb ischemia

Official title: miR-130b, angiogenesis, and diabetic critical limb ischemia

Funded at Brigham and Women's Hospital · NIH-10989897 · Data updated 2026-11-12

This study is looking at how a tiny molecule called miR-130b can help improve blood flow in the legs of people with diabetes who have serious circulation problems, with the goal of finding new ways to prevent amputations and help patients feel better.

More Critical Limb Ischemia research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startDecember 1, 2023
Project endNovember 30, 2027
Funding year2025
Award (this year)$594,287
NIH project number5R01HL167905-02
Project IDNIH-10989897 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are diabetic patients experiencing critical limb ischemia or severe peripheral artery disease.

Less likely to help

Patients without diabetes or those not experiencing critical limb ischemia may not benefit from this research.

What this research studies

This research focuses on understanding how a specific microRNA, miR-130b, affects blood vessel formation (angiogenesis) in patients with diabetes who suffer from critical limb ischemia (CLI). The study aims to identify the mechanisms by which miR-130b can enhance blood flow to the lower extremities, which is often compromised in diabetic patients. By analyzing blood samples and conducting experiments on cells, researchers hope to uncover new therapeutic targets that could improve limb perfusion and reduce the risk of amputation. The approach includes both laboratory studies and potential clinical applications to directly benefit patients.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that significantly improve blood flow and reduce the risk of amputation for diabetic patients with critical limb ischemia.

How similar studies have gone: Previous research has shown promising results in using microRNAs for therapeutic purposes, indicating potential success for this novel approach.

Where this research is happening

  • Brigham and Women's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Feinberg, Mark W — Brigham and Women's Hospital
  • Study coordinator: Feinberg, Mark W

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.